Ver video solo

Nonbiologic disease modifying antirheumatic drugs, or DMARDs for short, are a group of medications primarily used to treat rheumatoid arthritis. The most commonly used ones are methotrexate, sulfasalazine, leflunomide, and hydroxychloroquine. Now, in addition to rheumatoid arthritis, most of these medications have other indications. So, methotrexate can be used to treat psoriasis and certain cancers. Sulfasalazine is also indicated for ulcerative colitis. Finally, hydroxychloroquine can be also used to treat malaria and systemic lupus erythematosus.

Now, nonbiologic DMARDs can be administered orally, subcutaneously, intramuscularly, and intravenously. Once administered, they mainly work by inhibiting the immune response and suppressing inflammation.

However, nonbiologic DMARDs can cause some notable side effects, such as bone marrow suppression, which can lead to conditions like anemia and leukopenia; as well as severe skin reactions and stomatitis, or painful mouth sores. Other general side effects include gastrointestinal disturbances, such as anorexia, nausea, vomiting, and diarrhea. In addition, the immunosuppressive effects of these medications can lead to an increased risk of developing infections and certain cancers.

More specifically, methotrexate can also lead to pulmonary fibrosis, hepatotoxicity, and nephrotoxicity.
Next, sulfasalazine can result in hypersensitivity reactions like anaphylaxis and orange discoloration of the urine; while important side effects of leflunomide include heart palpitations, hepatoxicity, and interstitial lung disease.

Finally, hydroxychloroquine’s most common side effects are vision problems due to corneal or retinal damage. In addition, some clients may also experience neurological side effects, such as seizures, as well as cardiovascular side effects like heart failure, QT prolongation, and torsade de pointes.

Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology | Osmosis